Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 38.914 million compared to CNY 55.721 million a year ago. Operating loss was CNY 5.663 million compared to CNY 3.489 million a year ago. Net loss was CNY 3.068 million compared to CNY 24,694.68 a year ago. Basic loss per share from continuing operations was CNY 0.0252 compared to CNY 0.0002 a year ago.